1oy7
From Proteopedia
Line 4: | Line 4: | ||
|PDB= 1oy7 |SIZE=350|CAPTION= <scene name='initialview01'>1oy7</scene>, resolution 2.70Å | |PDB= 1oy7 |SIZE=350|CAPTION= <scene name='initialview01'>1oy7</scene>, resolution 2.70Å | ||
|SITE= | |SITE= | ||
- | |LIGAND= | + | |LIGAND= <scene name='pdbligand=P33:3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL'>P33</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene> |
|ACTIVITY= | |ACTIVITY= | ||
|GENE= BIRC7 OR KIAP OR MLIAP OR LIVIN ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]) | |GENE= BIRC7 OR KIAP OR MLIAP OR LIVIN ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]) | ||
+ | |DOMAIN= | ||
+ | |RELATEDENTRY=[[1oxn|1OXN]], [[1oxq|1OXQ]] | ||
+ | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1oy7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1oy7 OCA], [http://www.ebi.ac.uk/pdbsum/1oy7 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1oy7 RCSB]</span> | ||
}} | }} | ||
Line 32: | Line 35: | ||
[[Category: Kadkhodayan, S.]] | [[Category: Kadkhodayan, S.]] | ||
[[Category: Vucic, D.]] | [[Category: Vucic, D.]] | ||
- | [[Category: P33]] | ||
- | [[Category: ZN]] | ||
[[Category: apoptosis inhibition]] | [[Category: apoptosis inhibition]] | ||
[[Category: peptide complex]] | [[Category: peptide complex]] | ||
[[Category: zinc binding]] | [[Category: zinc binding]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 22:52:04 2008'' |
Revision as of 19:52, 30 March 2008
| |||||||
, resolution 2.70Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | , | ||||||
Gene: | BIRC7 OR KIAP OR MLIAP OR LIVIN (Homo sapiens) | ||||||
Related: | 1OXN, 1OXQ
| ||||||
Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
Coordinates: | save as pdb, mmCIF, xml |
Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP)
Overview
Melanoma inhibitor of apoptosis (ML-IAP) is a potent anti-apoptotic protein that is upregulated in a number of melanoma cell lines but not expressed in most normal adult tissues. Overexpression of IAP proteins, such as ML-IAP or the ubiquitously expressed X-chromosome-linked IAP (XIAP), in human cancers has been shown to suppress apoptosis induced by a variety of stimuli. Peptides based on the processed N-terminus of Smac/DIABLO can negate the ability of overexpressed ML-IAP or XIAP to suppress drug-induced apoptosis. Such peptides have been demonstrated to bind to the single baculovirus IAP repeat (BIR) of ML-IAP and the third BIR of XIAP with similar high affinities (approximately 0.5 microM). Herein, we use phage-display of naive peptide libraries and synthetic peptides to investigate the peptide-binding properties of ML-IAP-BIR and XIAP-BIR3. X-ray crystal structures of ML-IAP-BIR in complex with Smac- and phage-derived peptides, together with peptide structure-activity-relationship data, indicate that the peptides can be modified to provide increased binding affinity and selectivity for ML-IAP-BIR relative to XIAP-BIR3. For instance, substitution of Pro3' in the Smac-based peptide (AVPIAQKSE) with (2S,3S)-3-methylpyrrolidine-2-carboxylic acid [(3S)-methyl-proline] results in a peptide with 7-fold greater affinity for ML-IAP-BIR and about 100-fold specificity for ML-IAP-BIR relative to XIAP-BIR3.
About this Structure
1OY7 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)., Franklin MC, Kadkhodayan S, Ackerly H, Alexandru D, Distefano MD, Elliott LO, Flygare JA, Mausisa G, Okawa DC, Ong D, Vucic D, Deshayes K, Fairbrother WJ, Biochemistry. 2003 Jul 15;42(27):8223-31. PMID:12846571
Page seeded by OCA on Sun Mar 30 22:52:04 2008